Clinical Trial Update: GLU-xx Formulations in Individuals With Impaired Glucose Tolerance [Phase 1]

View source ↗

Summary

Phase 1 trial of GLU-xx formulations in individuals with impaired glucose tolerance was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• GLU-xx formulations

Snippet

Sponsor: Afexa Life Sciences Inc | Conditions: Impaired Glucose Tolerance | Phase 1 | Status: TERMINATED